Literature DB >> 9087412

Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.

H E Farrell1, H Vally, D M Lynch, P Fleming, G R Shellam, A A Scalzo, N J Davis-Poynter.   

Abstract

Herpesviruses, such as murine and human cytomegalovirus (MCMV and HCMV), can establish a persistent infection within the host and have diverse mechanisms as protection from host immune defences. Several herpesvirus genes that are homologous to host immune modulators have been identified, and are implicated in viral evasion of the host immune response. The discovery of a viral major histocompatibility complex (MHC) class I homologue, encoded by HCMV, led to speculation that it might function as an immune modulator and disrupt presentation of peptides by MHC class I to cytotoxic T cells. However, there is no evidence concerning the biological significance of this gene during viral infection. Recent analysis of the MCMV genome has also demonstrated the presence of a MHC class I homologue. Here we show that a recombinant MCMV, in which the gene encoding the class I homologue has been disrupted, has severely restricted replication during the acute stage of infection compared with wild-type MCMV. We demonstrate by in vivo depletion studies that natural killer (NK) cells are responsible for the attenuated phenotype of the mutant. Thus the viral MHC class I homologue contributes to immune evasion through interference with NK cell-mediated clearance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9087412     DOI: 10.1038/386510a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  74 in total

1.  Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution.

Authors:  M Wagner; S Jonjic; U H Koszinowski; M Messerle
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 2.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene.

Authors:  D A Leib; M A Machalek; B R Williams; R H Silverman; H W Virgin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 4.  Herpesvirus homologues of cellular genes.

Authors:  M Raftery; A Müller; G Schönrich
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

Review 5.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 6.  Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors.

Authors:  Michal Pyzik; Eve-Marie Gendron-Pontbriand; Nassima Fodil-Cornu; Silvia M Vidal
Journal:  Mamm Genome       Date:  2010-09-30       Impact factor: 2.957

Review 7.  Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.

Authors:  Fade Mahmoud; Bradley Shields; Issam Makhoul; Nathan Avaritt; Henry K Wong; Laura F Hutchins; Sara Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2017-05-17       Impact factor: 4.742

8.  Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells.

Authors:  Valentina Voigt; Catherine A Forbes; Joanne N Tonkin; Mariapia A Degli-Esposti; Hamish R C Smith; Wayne M Yokoyama; Anthony A Scalzo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 9.  Herpesvirus Evasion of Natural Killer Cells.

Authors:  Steffi De Pelsmaeker; Nicolas Romero; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

10.  Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor.

Authors:  D V Pastrana; N Raghavan; P FitzGerald; S W Eisinger; C Metz; R Bucala; R P Schleimer; C Bickel; A L Scott
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.